MFT
BIIB icon

Moisand Fitzgerald Tamayo’s Biogen BIIB Stock Holding History

Moisand Fitzgerald Tamayo’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-12
Closed -$3.11K – 586
2023
Q4 		$3.11K Buy
+12
New +$2.95K ﹤0.01% 477
2019
Q3 		– Sell
-11
Closed -$3K – 272
2019
Q2 		$3K Hold
11
– – ﹤0.01% 238
2019
Q1 		$3K Hold
11
– – ﹤0.01% 241
2018
Q4 		$3K Hold
11
– – ﹤0.01% 236
2018
Q3 		$4K Hold
11
– – ﹤0.01% 246
2018
Q2 		$3K Hold
11
– – ﹤0.01% 243
2018
Q1 		$3K Hold
11
– – ﹤0.01% 277
2017
Q4 		$4K Hold
11
– – ﹤0.01% 222
2017
Q3 		$3K Buy
+11
New +$3.26K ﹤0.01% 253

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Moisand Fitzgerald Tamayo's BIIB Position: Q1 2024 in Review

Moisand Fitzgerald Tamayo sold out of Biogen (BIIB) in Q1 2024, closing a stake of 12 shares — an estimated $3.11K sold.

Moisand Fitzgerald Tamayo first reported a position in BIIB in Q3 2017 and held it in 9 quarters. The position peaked at $4K in Q3 2018. 955 funds tracked by Wall St. Rank hold BIIB as of Q1 2024.

  • Moisand Fitzgerald Tamayo reported no remaining Biogen position as of Q1 2024 after selling out during the quarter.
  • Moisand Fitzgerald Tamayo sold 12 Biogen shares in Q1 2024, an estimated $3.11K.
  • Moisand Fitzgerald Tamayo first reported a position in Biogen in Q3 2017 and held it in 9 quarters.
  • Moisand Fitzgerald Tamayo's Biogen position peaked at $4K in Q3 2018.
  • 955 funds tracked by Wall St. Rank held Biogen as of Q1 2024.

Based on Moisand Fitzgerald Tamayo's 13F filing for Q1 2024, filed 16 Apr 2024.